AAAAAA
Results:
1-13
|
Results: 13
Authors:
Major, P
Lortholary, A
Hon, J
Abdi, E
Mills, G
Menssen, HD
Yunus, F
Bell, R
Body, J
Quebe-Fehling, E
Seaman, J
Citation: P. Major et al., Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: A pooled analysis of two randomized, controlled clinical trials, J CL ONCOL, 19(2), 2001, pp. 558-567
Authors:
Lortholary, A
Citation: A. Lortholary, Tumor-induced hypercalcemia. A review of the treatment by bisphosphonates, REV MED IN, 22(7), 2001, pp. 648-652
Authors:
Lortholary, A
Abadie-Lacourtoisie, S
Guerin, O
Mege, M
De Rauglaudre, G
Gamelin, E
Citation: A. Lortholary et al., Carcinoma of unknown primary site: 311 cases, B CANCER, 88(6), 2001, pp. 619-627
Authors:
Lortholary, A
Maillard, P
Delva, R
Boisdron-Celle, M
Perard, D
Vernillet, L
Besenval, M
Gamelin, E
Citation: A. Lortholary et al., Docetaxel in combination with 5-fluorouracil in patients with metastatic breast cancer previously treated with anthracycline-based chemotherapy: a phase I, dose-finding study, EUR J CANC, 36(14), 2000, pp. 1773-1780
Authors:
Felizot, L
Lortholary, A
Troussier, J
De Rauglaude, G
Mege, M
Citation: L. Felizot et al., Multiple opacities on the chest x-ray of a young man disclosing pulmonary sarcoidosis, PRESSE MED, 29(17), 2000, pp. 977-977
Authors:
Labreze, L
Bui, BN
Coindre, JM
Lortholary, A
Thyss, A
Bertrand, G
Le Doussal, V
Renaud-Salis, JL
Citation: L. Labreze et al., Case report forum: the example of French sarcoma group multidisciplinary discussion tools, B CANCER, 87(4), 2000, pp. 341-347
Authors:
Laplace-Marieze, V
Presneau, N
Sylvain, V
Kwiatkowski, F
Lortholary, A
Hardouin, A
Bignon, YJ
Citation: V. Laplace-marieze et al., Systematic sequencing of the BRCA-1 coding region for germ-line mutation detection in 70 French high-risk families, INT J ONCOL, 14(5), 1999, pp. 971-977
Authors:
Body, JJ
Lortholary, A
Romieu, G
Vigneron, AM
Ford, J
Citation: Jj. Body et al., A dose-finding study of zoledronate in hypercalcemic cancer patients, J BONE MIN, 14(9), 1999, pp. 1557-1561
Authors:
Felizot, L
Lortholary, A
Tuchais, C
Delva, R
Gamelin, E
Citation: L. Felizot et al., Unique bone metastasis in the foot disclosing carcinoma of the rectum, PRESSE MED, 28(34), 1999, pp. 1879-1879
Authors:
Gamelin, E
Boissdron-Celle, M
Guerin-Meyer, V
Delva, R
Lortholary, A
Genevieve, F
Larra, F
Ifrah, N
Robert, J
Citation: E. Gamelin et al., Correlation between uracil and dihydrouracil plasma ratio, fluorouracil (5-FU) pharmacokinetic parameters, and tolerance in patients with advanced colorectal cancer: A potential interest for predicting 5-FU toxicity and determining optimal 5-FU dosage, J CL ONCOL, 17(4), 1999, pp. 1105-1110
Authors:
Sobol, H
Bignon, YJ
Bonaiti, C
Cuisenier, J
Lasset, C
Lortholary, A
Nogues, C
Stoppa-Lyonnet, D
Eisinger, F
Citation: H. Sobol et al., Four years analysis of cancer genetic clinics activity in France from 1994to 1997: A survey on 801 patients, DIS MARKER, 15(1-3), 1999, pp. 15-29
Authors:
Gosse-Brun, S
Sauvaigo, S
Daver, A
Page, M
Lortholary, A
Larra, F
Bignon, YJ
Bernard-Gallon, D
Citation: S. Gosse-brun et al., Specific H-ras minisatellite alleles in breast cancer susceptibility, ANTICANC R, 19(6B), 1999, pp. 5191-5196
Authors:
Presneau, N
Laplace-Marieze, V
Sylvain, V
Lortholary, A
Hardouin, A
Bernard-Gallon, D
Bignon, YJ
Citation: N. Presneau et al., Mutation by deletion-insertion in BRCA-1 gene in three unrelated French breast ovarian cancer families: possible implication of a mobile element, B CANCER, 86(4), 1999, pp. 385-390
Risultati:
1-13
|